unveiled a novel player in the intricate game of tumor immune evasion: SMARCAL1, linked to DNA repair, emerges as a dual regulator with a surprising ability to modulate both innate immune signaling and PD‐L1 expression. The gene discussed is CD274; the disease is neoplasm.